VBL Therapeutics Announces Third Quarter 2018 Financial Results
Conference Call and Webcast at 8:30am Eastern Time Today TEL AVIV, Israel, Nov. 20, 2018 (GLOBE NEWSWIRE) — VBL Therapeutics […]
Conference Call and Webcast at 8:30am Eastern Time Today TEL AVIV, Israel, Nov. 20, 2018 (GLOBE NEWSWIRE) — VBL Therapeutics […]
LEIDEN, the Netherlands, Nov. 20, 2018 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through […]
NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines […]
NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development […]
EDINBURGH, United Kingdom, Nov. 20, 2018 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving […]
CAMBRIDGE, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that […]
WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the […]
CRESTWOOD, Ky. and WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused […]
RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2018 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has […]
(All amounts in this release are in Canadian Dollars) KANATA, Ontario, Nov. 20, 2018 (GLOBE NEWSWIRE) — Calian Group Ltd. […]